Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of LAS100977 in COPD
NCT01425814Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abediterol in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Aug 2011; status: completed.
02
Drugs
abediterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01425814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01425814.